Caxton Associates (UK)’s Clorox CLX Stock Holding History

Caxton Associates (UK)’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$504K	–	811
2025 Q4	$504K	Buy	+5,000	New	+$543K	0.01%	499
2025 Q2	–	Sell	-3,941	Closed	-$580K	–	716
2025 Q1	$580K	Buy	+3,941	New	+$602K	0.02%	441

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Caxton Associates (UK)'s CLX Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Clorox (CLX) in Q1 2026, closing a stake of 5,000 shares — an estimated $504K sold.

Caxton Associates (UK) first reported a position in CLX in Q1 2025 and held it in 2 quarters. The position peaked at $580K in Q1 2025. 1,086 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Caxton Associates (UK) reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
Caxton Associates (UK) sold 5,000 Clorox shares in Q1 2026, an estimated $504K.
Caxton Associates (UK) first reported a position in Clorox in Q1 2025 and held it in 2 quarters.
Caxton Associates (UK)'s Clorox position peaked at $580K in Q1 2025.
1,086 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.